PPARδ agonists suppress angiogenesis in a VEGFR2-dependent manner (Q54403511)

29 May 2018

title

PPARδ agonists suppress angiogenesis in a VEGFR2-dependent manner (English)

1 reference

https://api.crossref.org/works/10.1007/S00403-010-1091-Y

19 August 2024

3

Monika Doll

1 reference

29 May 2018

Roland Kaufmann

4

object named as

Roland Kaufmann

1 reference

29 May 2018

Markus Meissner

1

object named as

Markus Meissner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21046127

19 August 2024

author name string

Igor Hrgovic

2

1 reference

29 May 2018

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21046127

19 August 2024

publication date

3 November 2010

1 reference

29 May 2018

full work available at URL

http://link.springer.com/content/pdf/10.1007/s00403-010-1091-y.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/S00403-010-1091-Y

http://link.springer.com/article/10.1007/s00403-010-1091-y/fulltext.html

19 August 2024

1 reference

https://api.crossref.org/works/10.1007/S00403-010-1091-Y

http://link.springer.com/content/pdf/10.1007/s00403-010-1091-y

19 August 2024

1 reference

https://api.crossref.org/works/10.1007/S00403-010-1091-Y

Archives of Dermatological Research

19 August 2024

published in

1 reference

29 May 2018

volume

303

1 reference

29 May 2018

issue

1

1 reference

29 May 2018

page(s)

41-47

1 reference

29 May 2018

PPAR delta: a dagger in the heart of the metabolic syndrome

cites work

1

1 reference

https://api.crossref.org/works/10.1007/S00403-010-1091-Y

Ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase-2 enhances inhibition of skin tumorigenesis

19 August 2024

2

1 reference

https://api.crossref.org/works/10.1007/S00403-010-1091-Y

PPAR-β/δ agonists for Type 2 diabetes and dyslipidemia: an adopted orphan still looking for a home

19 August 2024

3

1 reference

https://api.crossref.org/works/10.1007/S00403-010-1091-Y

Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets

19 August 2024

4

1 reference

https://api.crossref.org/works/10.1007/S00403-010-1091-Y

The role of peroxisome proliferator-activated receptor-beta/delta in epithelial cell growth and differentiation

19 August 2024

5

1 reference

https://api.crossref.org/works/10.1007/S00403-010-1091-Y

Positive and negative modulation of angiogenesis by VEGFR1 ligands

19 August 2024

6

1 reference

https://api.crossref.org/works/10.1007/S00403-010-1091-Y

Angiogenesis in cancer and other diseases

19 August 2024

7

1 reference

https://api.crossref.org/works/10.1007/S00403-010-1091-Y

PPARs: the vasculature, inflammation and hypertension

19 August 2024

8

1 reference

https://api.crossref.org/works/10.1007/S00403-010-1091-Y

VEGF-targeted therapy: mechanisms of anti-tumour activity.

19 August 2024

9

1 reference

https://api.crossref.org/works/10.1007/S00403-010-1091-Y

Rat PPARs: quantitative analysis in adult rat tissues and regulation in fasting and refeeding

19 August 2024

10

1 reference

https://api.crossref.org/works/10.1007/S00403-010-1091-Y

Ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) inhibits cell growth in a mouse mammary gland cancer cell line

19 August 2024

11

1 reference

https://api.crossref.org/works/10.1007/S00403-010-1091-Y

Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines.

19 August 2024

12

1 reference

https://api.crossref.org/works/10.1007/S00403-010-1091-Y

Quantitative expression patterns of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) protein in mice

19 August 2024

13

1 reference

https://api.crossref.org/works/10.1007/S00403-010-1091-Y

PPAR agonists: multimodal drugs for the treatment of type-2 diabetes

19 August 2024

14

1 reference

https://api.crossref.org/works/10.1007/S00403-010-1091-Y

Enhancement of PPAR-beta activity by repetitive low-grade H(2)O(2) stress protects human umbilical vein endothelial cells from subsequent oxidative stress-induced apoptosis

19 August 2024

16

1 reference

https://api.crossref.org/works/10.1007/S00403-010-1091-Y

Inhibition of adult liver progenitor (oval) cell growth and viability by an agonist of the peroxisome proliferator activated receptor (PPAR) family member gamma, but not alpha or delta

19 August 2024

17

1 reference

https://api.crossref.org/works/10.1007/S00403-010-1091-Y

Biphasic effects of 15-deoxy-delta(12,14)-prostaglandin J(2) on glutathione induction and apoptosis in human endothelial cells

19 August 2024

18

1 reference

https://api.crossref.org/works/10.1007/S00403-010-1091-Y

Peroxisome proliferator-activated receptor {delta} activators induce IL-8 expression in nonstimulated endothelial cells in a transcriptional and posttranscriptional manner

19 August 2024

19

1 reference

https://api.crossref.org/works/10.1007/S00403-010-1091-Y

VEGF receptor signalling - in control of vascular function

19 August 2024

20

1 reference

https://api.crossref.org/works/10.1007/S00403-010-1091-Y

Biochimica et Biophysica Acta

19 August 2024

21

1796

230

JM Peters

2009

1 reference

https://api.crossref.org/works/10.1007/S00403-010-1091-Y

Transactivation of vascular endothelial growth factor receptor-2 by interleukin-8 (IL-8/CXCL8) is required for IL-8/CXCL8-induced endothelial permeability

19 August 2024

22

1 reference

https://api.crossref.org/works/10.1007/S00403-010-1091-Y

Activation of PPARbeta/delta induces endothelial cell proliferation and angiogenesis

19 August 2024

23

1 reference

https://api.crossref.org/works/10.1007/S00403-010-1091-Y

Biphasic effect of pioglitazone on isolated human endothelial progenitor cells: involvement of peroxisome proliferator-activated receptor-gamma and transforming growth factor-beta1

19 August 2024

24

1 reference

https://api.crossref.org/works/10.1007/S00403-010-1091-Y

PPARalpha and PPARdelta activators inhibit cytokine-induced nuclear translocation of NF-kappaB and expression of VCAM-1 in EAhy926 endothelial cells

19 August 2024

25

1 reference

https://api.crossref.org/works/10.1007/S00403-010-1091-Y

Activation of peroxisome proliferator-activated receptor beta/delta inhibits lipopolysaccharide-induced cytokine production in adipocytes by lowering nuclear factor-kappaB activity via extracellular signal-related kinase 1/2.

19 August 2024

26

1 reference

https://api.crossref.org/works/10.1007/S00403-010-1091-Y

Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated

19 August 2024

27

1 reference

https://api.crossref.org/works/10.1007/S00403-010-1091-Y

U-61, 431F, a stable prostacyclin analogue, inhibits the proliferation of bovine vascular smooth muscle cells with little antiproliferative effect on endothelial cells

19 August 2024

28

1 reference

https://api.crossref.org/works/10.1007/S00403-010-1091-Y

Activation of peroxisome proliferator-activated receptor delta stimulates the proliferation of human breast and prostate cancer cell lines.

19 August 2024

29

1 reference

https://api.crossref.org/works/10.1007/S00403-010-1091-Y

Activation of mouse and human peroxisome proliferator-activated receptors (alpha, beta/delta, gamma) by perfluorooctanoic acid and perfluorooctane sulfonate.

19 August 2024

30

1 reference

https://api.crossref.org/works/10.1007/S00403-010-1091-Y

Peroxisome proliferator-activated receptors: from transcriptional control to clinical practice

19 August 2024

31

1 reference

https://api.crossref.org/works/10.1007/S00403-010-1091-Y

Vascular-specific growth factors and blood vessel formation

19 August 2024

33

1 reference

https://api.crossref.org/works/10.1007/S00403-010-1091-Y

19 August 2024

Identifiers

1 reference

29 May 2018

1 reference

29 May 2018